NAVSTEL
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
Approval overview NAVSTEL is listed in Drugs@FDA under application 022193 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE Form and strength SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML Sponsor ALCON PHARMS LTD Submission history Latest submission status date: 2008-07-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview NAVSTEL is listed in Drugs@FDA under application 022193 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE Form and strength SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML Sponsor ALCON PHARMS LTD Submission history Latest submission status date: 2008-07-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.